The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).
 
Daniel Vargas Almeida
No Relationships to Disclose
 
Cleyton Z. Oliveira
No Relationships to Disclose
 
Andrey Soares
No Relationships to Disclose
 
Denis L Jardim
No Relationships to Disclose
 
Diogo Assed Bastos
Consulting or Advisory Role - Bayer; Janssen-Cilag; Roche
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
 
Fernando C. Maluf
No Relationships to Disclose
 
Gustavo Werutsky
No Relationships to Disclose
 
Fernando Sabino M Monteiro
No Relationships to Disclose
 
Vinicius Carrera Souza
No Relationships to Disclose
 
Andre Poisl Fay
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Fabio A. B. Schutz
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche